Loading...
Uploaded by Bioceros on Mar 24, 2010
Biotechnology company Bioceros presents its hybrid business model for the production of monoclonal antibodies and other proteins.
Science & Technology
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)